Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs ProShares Ultra Bloomberg Natural Gas ETF (BOIL) Price & Performance

ADMA Biologics Inc
ProShares Ultra Bloomberg Natural Gas ETF

Price performance

Price movement over the last 24 hours

Key statistics

ADMA Biologics Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? ADMA Biologics Inc trades at $9.28 (market cap $2.13B), while ProShares Ultra Bloomberg Natural Gas ETF trades at $26.68. Which is the better fit depends on your goals.

ADMABOIL
Market Cap
$2.13B
Sector
HealthLeveraged / Inverse
52-Week High
$20.38$98.62
52-Week Low
$7.60$24.30
Enterprise Value
$2.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

ProShares Ultra Bloomberg Natural Gas ETF

BOIL trades at $26.65, up 0.79% today, but technical indicators signal a bearish trend with 14 sell signals versus 1 buy. The stock recently underwent a 1:2 split on May 28, 2026. Natural gas futures volatility, driven by weather forecasts and LNG demand, heavily influences price action. Key support sits at $25-26, with resistance at $27-28.

Outlook remains cautious due to technical weakness and reliance on volatile commodity prices. Investment opportunity exists for tactical traders betting on natural gas price swings, but risks include contango erosion and weather-dependent demand. Long-term value erosion is a significant concern given the ETF's structure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About ProShares Ultra Bloomberg Natural Gas ETF

BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.

Read more on BOIL